[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MA27467A1 - Quinolones anti-microbiens, leurs compositions et utilisations - Google Patents

Quinolones anti-microbiens, leurs compositions et utilisations

Info

Publication number
MA27467A1
MA27467A1 MA28065A MA28065A MA27467A1 MA 27467 A1 MA27467 A1 MA 27467A1 MA 28065 A MA28065 A MA 28065A MA 28065 A MA28065 A MA 28065A MA 27467 A1 MA27467 A1 MA 27467A1
Authority
MA
Morocco
Prior art keywords
microbial
quinolones
compositions
compounds
effective
Prior art date
Application number
MA28065A
Other languages
English (en)
Inventor
Benoit Ledoussal
Xiufeng Eric Hu
Ji-In Kim Almstead
Jeffrey Lyle Gray
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MA27467A1 publication Critical patent/MA27467A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Les composés de la formule suivante (I) sont efficaces en tant qu'agents anti-microbiens.
MA28065A 2002-07-31 2005-01-25 Quinolones anti-microbiens, leurs compositions et utilisations MA27467A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40001402P 2002-07-31 2002-07-31

Publications (1)

Publication Number Publication Date
MA27467A1 true MA27467A1 (fr) 2005-08-01

Family

ID=31715691

Family Applications (1)

Application Number Title Priority Date Filing Date
MA28065A MA27467A1 (fr) 2002-07-31 2005-01-25 Quinolones anti-microbiens, leurs compositions et utilisations

Country Status (17)

Country Link
US (1) US6900224B2 (fr)
EP (1) EP1532137A2 (fr)
JP (1) JP2005536532A (fr)
KR (1) KR20050026074A (fr)
CN (1) CN1671690A (fr)
AU (1) AU2003259169A1 (fr)
BR (1) BR0313420A (fr)
CA (1) CA2493146A1 (fr)
IL (1) IL166041A0 (fr)
MA (1) MA27467A1 (fr)
MX (1) MXPA05001180A (fr)
NO (1) NO20051082L (fr)
NZ (1) NZ537203A (fr)
PL (1) PL375388A1 (fr)
RU (1) RU2005105337A (fr)
WO (1) WO2004014893A2 (fr)
ZA (1) ZA200500877B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1015445B1 (fr) * 1997-09-15 2009-02-25 The Procter & Gamble Company Quinolones antimicrobiennes, compositions et utilisations de celles-ci
CN1414856A (zh) * 1999-12-28 2003-04-30 帝国制药株式会社 治疗瘙痒的外用制剂
JP2006522827A (ja) * 2003-04-07 2006-10-05 サイリーン ファーマシューティカルズ インコーポレーティッド 置換キノベンゾオキサジン類似体
US7354916B2 (en) * 2003-04-07 2008-04-08 Cylene Pharmaceuticals Substituted quinobenzoxazine analogs
US7163948B2 (en) * 2003-04-07 2007-01-16 Cylene Pharmaceuticals, Inc. Heterocyclic substituted 1,4-dihydri-4ox9-1,8-naphthyridine analogs
US7507727B2 (en) * 2003-04-07 2009-03-24 Cylene Pharmaceuticals, Inc. Substituted quinobenzoxazine analogs and methods of using thereof
BRPI0515319A (pt) * 2004-09-17 2008-07-22 Cylene Pharmaceuticals Inc análogos de quinolona
US7652134B2 (en) * 2004-09-17 2010-01-26 Cylene Pharmaceuticals, Inc. Methods for converting quinolone esters into quinolone amides
WO2007110836A1 (fr) * 2006-03-28 2007-10-04 The Procter & Gamble Company Procédé de réduction par un hydrure servant à préparer des intermédiaires de quinolones
CA2647454A1 (fr) * 2006-03-28 2007-10-04 The Procter & Gamble Company Procede de couplage pour preparer des intermediaires quinolone
WO2007110834A2 (fr) * 2006-03-28 2007-10-04 The Procter & Gamble Company Malates et formes polymorphes de l'acide (3s,5s)-7-[3-amino-5-méthyl-pipéridinyl]-1-cyclopropyl-1,4-dihydro-8-méthoxy-4-oxo-3-quinoléine-carboxylique
ATE549334T1 (de) * 2006-11-20 2012-03-15 Bristol Myers Squibb Co 7,8-dihydro-1,6-naphthyridin-5(6h)-one und verwandte bicyclische verbindungen als hemmer der dipeptidyl-peptidase iv sowie verfahren
US8658183B2 (en) * 2007-08-09 2014-02-25 Taigen Biotechnology Company, Ltd. Antimicrobial parenteral formulation
MX2010003685A (es) 2007-10-05 2010-06-02 Cylene Pharmaceuticals Inc Analogos de quinolona y metodos relacionados con los mismos.
JP2011526887A (ja) * 2008-07-01 2011-10-20 タイゲン バイオテクノロジー カンパニー，リミテッド 抗生物質耐性菌感染症の治療
CN101618039B (zh) * 2008-07-02 2012-04-11 太景生物科技股份有限公司 肺炎的治疗药物
FR2936798B1 (fr) * 2008-10-03 2012-09-28 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens.
FR2937034B1 (fr) * 2008-10-10 2012-11-23 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens
FR2936951B1 (fr) * 2008-10-10 2010-12-03 Novexel Nouvelles combinaisons de composes heterocycliques azotes antibacteriens avec d'autres composes antibacteriens et leur utilisation comme medicaments
NZ592831A (en) * 2008-12-15 2013-06-28 Taigen Biotechnology Co Ltd Stereoselective synthesis of piperidine derivatives
CN102093260B (zh) * 2009-12-14 2014-03-05 太景生物科技股份有限公司 哌啶衍生物的立体有择合成
TWI730013B (zh) 2015-11-20 2021-06-11 生華生物科技股份有限公司 用於治療癌症的四環喹諾酮類似物組合療法
US9957282B2 (en) 2015-12-14 2018-05-01 Senhwa Biosciences, Inc. Crystalline forms of quinolone analogs and their salts
WO2017112719A1 (fr) 2015-12-23 2017-06-29 Merck Sharp & Dohme Corp. Modulateurs allostériques 6,7-dihydro-5h-pyrrolo[3,4-b] pyridine-5-one du récepteur de l'acétylcholine muscarinique m4
WO2017107089A1 (fr) 2015-12-23 2017-06-29 Merck Sharp & Dohme Corp. Modulateurs allostériques 3-(1h-pyrazol-4-yl)pyridine du récepteur muscarinique m4 de l'acétylcholine
WO2018112840A1 (fr) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. Modulateurs allostériques d'éther d'hétéroarylpipéridine 6, 5-fusionnés du récepteur muscarinique d'acétylcholine m4
WO2018112842A1 (fr) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. Modulateurs allostériques d'éther hétéroarylpipéridine 6,6-fusionné du récepteur muscarinique de l'acétylcholine m4
WO2018112843A1 (fr) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. Modulateurs allostériques d'éther hétéroarylpipéridine du récepteur muscarinique de l'acétylcholine m4
WO2019000237A1 (fr) 2017-06-27 2019-01-03 Merck Sharp & Dohme Corp. Modulateurs allostériques de 3-(1h-pyrazol-4-yl)pyridine du récepteur muscarinique m4 de l'acétylcholine
WO2019000238A1 (fr) 2017-06-27 2019-01-03 Merck Sharp & Dohme Corp. Modulateurs allostériques de 5-(pyridin-3-yl)oxazole du récepteur muscarinique m4 de l'acétylcholine
WO2019000236A1 (fr) 2017-06-27 2019-01-03 Merck Sharp & Dohme Corp. Modulateurs allostériques de 3-(1h-pyrazol-4-yl)pyridine du récepteur muscarinique m4 de l'acétylcholine
AU2019227294B2 (en) 2018-02-15 2023-06-15 Senhwa Biosciences, Inc. Quinolone analogs and their salts, compositions, and method for their use
ES2956316T3 (es) * 2018-04-25 2023-12-19 Elanco Animal Health Gmbh Proceso para la hidrólisis de ésteres carboxílicos de quinolona

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE117685T1 (de) 1988-05-19 1995-02-15 Chugai Pharmaceutical Co Ltd Chinoloncarbonsäure-derivate.
WO1995010519A1 (fr) * 1993-10-14 1995-04-20 Abbott Laboratories Composes du type de la quinolizinone
EP0871628A1 (fr) * 1995-06-06 1998-10-21 Abbott Laboratories Composes de type quinolizinone
KR100241673B1 (ko) * 1997-08-09 2000-03-02 김충섭 퀴놀리진 카르복실산 유도체
EP1015445B1 (fr) * 1997-09-15 2009-02-25 The Procter & Gamble Company Quinolones antimicrobiennes, compositions et utilisations de celles-ci
US6387928B1 (en) * 1997-09-15 2002-05-14 The Procter & Gamble Co. Antimicrobial quinolones, their compositions and uses
GB9822440D0 (en) 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
GB9914486D0 (en) 1999-06-21 1999-08-18 Smithkline Beecham Plc Medicaments
WO2001053273A1 (fr) * 2000-01-24 2001-07-26 Warner-Lambert Company Agents antibacteriens contenant 3-aminoquinazolin-2,4-dione
JP2004515548A (ja) 2000-12-14 2004-05-27 ザ プロクター アンド ギャンブル カンパニー 抗微生物キノロン

Also Published As

Publication number Publication date
MXPA05001180A (es) 2005-05-16
WO2004014893A3 (fr) 2004-04-08
NZ537203A (en) 2007-02-23
RU2005105337A (ru) 2006-01-20
EP1532137A2 (fr) 2005-05-25
US6900224B2 (en) 2005-05-31
ZA200500877B (en) 2006-02-20
CA2493146A1 (fr) 2004-02-19
PL375388A1 (en) 2005-11-28
KR20050026074A (ko) 2005-03-14
BR0313420A (pt) 2005-06-28
CN1671690A (zh) 2005-09-21
AU2003259169A1 (en) 2004-02-25
WO2004014893A2 (fr) 2004-02-19
NO20051082L (no) 2005-04-29
JP2005536532A (ja) 2005-12-02
US20040038975A1 (en) 2004-02-26
IL166041A0 (en) 2006-01-15

Similar Documents

Publication Publication Date Title
MA27467A1 (fr) Quinolones anti-microbiens, leurs compositions et utilisations
BR0107811A (pt) Composição herbicida
CY1109886T1 (el) Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες
BR0116217A (pt) Quinolonas antimicrobianas, composição farmacêutica, bem como aplicação farmacêutica das referidas quinolonas
RS52625B (en) FLUORO SUBSTITUTED OMEGA-CARBOXYARYL DIPHENYL UREA FOR TREATMENT AND PREVENTION OF DISEASES AND DISEASES
MA27643A1 (fr) Utilisation de n-alkyl-4-methyleneamino-3-hydroxy-2-pyridones en tant qu'agents antimicrobiens
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
CY1106522T1 (el) Ετepοκυκλικη ενωση και αντικαρκινικο μεσο που πepιεχει την ιδια ως δραστικο συστατικο
MA29141B1 (fr) Pyrrolopyrazoles, servant de puissants inhibiteurs de kinases
ATE318267T1 (de) Einige alkylendiamin-substituierte heterocyclen
ATE213491T1 (de) Fungizide 2-methoxybenzophenone
MA27180A1 (fr) N-aryl-2-oxazolidinone-5-carboxamides et leurs derives, et leur utilisation comme agents antibacteriens
DK1200418T3 (da) Nematodicide trifluorbutener
ES2243579T3 (es) Derivados de pirazolopirideno.
BR0116319A (pt) Composição herbicida
ATE511352T1 (de) Antimikrobielle zusammensetzungen
ATE335728T1 (de) 5-substituierte alkylaminopyrazol-derivate als pestizide
BR9902084A (pt) Heterociclos.
MA27501A1 (fr) Derives d'imidazoquinoline en tant que ligands recepteurs de l'adenosine a3
HRP20050517B1 (hr) N-sulfonil-4-metilenamino-3-hidroksi-2-piridoni kao antimikrobni lijekovi
HRP20060402A2 (en) Pyridine derivatives of alkyl oxindoles as 5-ht7 receptor active agents
TR200402343T4 (tr) Antitrombotik ve antikoagulant etken olarak kullanım için N-(Heterosiklil) benzen veya piridin sulfonamit
BR9907426A (pt) Tetrahidronaftalenos
ATE276259T1 (de) Dihydroporphyrinderivate und ihre verwendung
ATE252537T1 (de) Substituierte 2-hydroxybenzophenone, ihre herstellung, ihre verwendung als fungizide und ihre fungizide zusammensetzungen